Warburg leads $255m Series C in HK-based AI drug discovery firm Insilico Medicine

Warburg leads $255m Series C in HK-based AI drug discovery firm Insilico Medicine

Alex Zhavoronkov, founder and CEO of Hong Kong-based Insilico Medicine

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter